• Davern Capital sees GLP-1 Opportunities Beyond Obesity

  • Jun 14 2024
  • Length: 10 mins
  • Podcast

Davern Capital sees GLP-1 Opportunities Beyond Obesity

  • Summary

  • Davern Capital’s founder, Elie Kobrin, approaches the biopharma market from a long/short perspective – but as a former doctor, he also speaks the language of medicine. He explains the fund’s approach and offers insights on hot topics in the current market.

    Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about Davern Capital sees GLP-1 Opportunities Beyond Obesity

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.